Ensign Peak Advisors’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$302K	Hold	5,194	–	–	﹤0.01%	1123
2025 Q4	$233K	Sell	5,194 -10,050	-66%	-$422K	﹤0.01%	1240
2025 Q3	$612K	Sell	15,244 -10,850	-42%	-$382K	﹤0.01%	1299
2025 Q2	$817K	Hold	26,094	–	–	﹤0.01%	1365
2025 Q1	$875K	Hold	26,094	–	–	﹤0.01%	1325
2024 Q4	$1.02M	Sell	26,094 -136,970	-84%	-$5.66M	﹤0.01%	1306
2024 Q3	$6.42M	Hold	163,064	–	–	0.01%	557
2024 Q2	$6.36M	Hold	163,064	–	–	0.01%	564
2024 Q1	$7.02M	Sell	163,064 -1,316	-0.8%	-$60.5K	0.01%	540
2023 Q4	$7.57M	Hold	164,380	–	–	0.02%	514
2023 Q3	$5.62M	Hold	164,380	–	–	0.01%	535
2023 Q2	$6.33M	Hold	164,380	–	–	0.01%	526
2023 Q1	$5.88M	Hold	164,380	–	–	0.01%	524
2022 Q4	$6.48M	Buy	164,380 +50,900	+45%	+$1.85M	0.01%	499
2022 Q3	$4.1M	Buy	113,480 +57,189	+102%	+$2.06M	0.01%	571
2022 Q2	$1.71M	Buy	56,291 +47,771	+561%	+$1.44M	﹤0.01%	863
2022 Q1	$260K	Sell	8,520 -28,595	-77%	-$856K	﹤0.01%	1801
2021 Q4	$1.16M	Buy	37,115 +5,600	+18%	+$167K	﹤0.01%	1199
2021 Q3	$482K	Buy	+31,515	New	+$548K	﹤0.01%	1631